ABOUT VECTANS PHARMA
NEWS

China’s NMPA approves authorization of commercialization for Oravig®
China’s NMPA has granted the approval of commercialization for Oravig®

Happy New Year!
In 2021, Vectans Pharma will offer new therapeutic perspectives based on Lauriad® technology.